🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Sexually Transmitted Disease (STD)

ADELANTE: A Randomized Controlled Trial to Improve Engagement in Care for Latinos With HIV NCT06274632NA2 sites📍 Miami📍 Houston Massachusetts General Hospital · Tests: ADELANTE The Integrated Female Sexually Transmitted Infection Testing for HIV Epidemic Control Through PrEP (IN-STEP) Study NCT06743204NA1 site📍 Kalisizo Johns Hopkins University · Tests: Self-Reported Risk Screening for PrEP and Diagnostic STI testing, Self-reported risk screening for PrEP and syndromic m… Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3) NCT06075264Phase 25 sites📍 Fort Myers📍 Indianapolis📍 Cleveland Frantz Viral Therapeutics, LLC · Tests: Artesunate ointment, Placebo ointment A Study to Investigate Pharmacokinetics (PK), Safety, and Tolerability of VH4367310 in Healthy Adult Participants NCT07818915Phase 12 sites📍 Glendale📍 Baltimore ViiV Healthcare · Tests: VH4367310, Placebo Immuno-virological Evaluation of Persons Living With HIV (PLWH) NCT05973825NA1 site📍 Ghent University Hospital, Ghent · Tests: Leucapheresis Prevalence and Clinical Implications of HPV Infection in Male IBD Patients NCT05911750n/a1 site📍 Barcelona Fundació Institut de Recerca de l'Hospital de la Santa Creu… · Tests: Anal pap smear and oral swab for cytology and HPV testing Development of a New Family of HIV Latency Regulators (LRAs) Targeting the Tat Viral Protein NCT06441123n/a1 site📍 Montpellier University Hospital, Montpellier · Tests: Blood Sampling Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India NCT07209917NA4 sites📍 Bangalore📍 Bangalore📍 Bangalore University of California, Irvine · Tests: SAKHI HPV Intervention, Enhanced Standard of Care (SOC+) A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study) NCT07202546Phase 2123 sites📍 Bakersfield📍 Palm Springs📍 West Hollywood ViiV Healthcare · Tests: VH4524184, Emtricitabine (FTC) and tenofovir alafenamide (TAF) Fixed Dose Combination (FDC) tablets, Dolutegravir / Lam… Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus NCT05918510n/a1 site📍 Rome Regina Elena Cancer Institute · Tests: Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx A Mobile Gaming App to Improve Adherence to PrEP NCT05762705NA3 sites📍 Boston📍 Jackson📍 Providence Rhode Island Hospital · Tests: Multilevel Gaming Adherence Intervention, Treatment as Usual + To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years NCT06756269Phase 21 site📍 Nanning Shanghai Bovax Biotechnology Co., Ltd. · Tests: Medium dose for 15-HPV vaccine, High dose for 15-HPV vaccine, Placebo, 9-HPV vaccine Polypharmacy on Healthy Aging in People Living With HIV Over the Age of 75 NCT07388394NA1 site📍 Nice Centre Hospitalier Universitaire de Nice · Tests: interview with advanced practice nurse Periodic Presumptive Treatment vs. doxyPEP for STI Control in Kenyan MSM NCT06468462Phase 43 sites📍 Kisumu📍 Mombasa📍 Nairobi University of Washington · Tests: WHO-recommended periodic presumptive treatment, Doxycycline post-exposure prophylaxis Platform Trial For Cryptococcal Meningitis (PLATFORM-CM) NCT06666322Phase 2, Phase 32 sites📍 Kampala📍 Mbarara David Boulware · Tests: Standard of care, Oteseconazole - antifungal therapy 1, Turletricin injection - antifungal therapy 2, Turletricin Injec… Development of a Predictive Model for Sexually Transmitted Infections in Individuals Using Pre-Exposure Prophylaxis for HIV in Spain NCT06860945n/a26 sites📍 Almería📍 Cadiz📍 Cartagena Hospital Universitario de Valme · Tests: No Intervention: Observational Cohort A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV NCT05495906Phase 410 sites📍 Surrey📍 Vancouver📍 Winnipeg University of British Columbia · Tests: Nonavalent HPV vaccine Efficacy and Safety of ACC017 Tablets Compared With Dolutegravir Sodium Tablets in Treatment-Naïve Adults With Human Immunodeficiency Virus Type 1 (HIV-1) NCT07711223Phase 1, Phase 21 site📍 Beijing Jiangsu Aidea Pharmaceutical Group Co., Ltd. · Tests: ACC017+FTC/TAF, DTG+FTC/TAF Identifying Challenges to Healthy Aging in Persons With Human Immunodeficiency Virus (HIV) Age 50 and Older NCT05858034NA1 site📍 Winston-Salem Wake Forest University Health Sciences · Tests: Customized activity plan, Customized nutrition plan The Effect of Chimeric Antigen Receptor (CAR)-T Cell Therapy on the Reconstitution of HIV-specific Immune Function NCT03240328Phase 11 site📍 Guangzhou Guangzhou 8th People's Hospital · Tests: CAR-T cells Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation NCT06793410Phase 25 sites📍 Lund📍 Stockholm📍 Uppsala Vastra Gotaland Region · Tests: Early start post-transplant vaccination with Gardasil 9®, Late post-transplant vaccination with Gardasil 9® Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therapy Since Primary-infection, Chronic Phase, or Never Treated. NCT04160455n/a1 site📍 Orléans Centre Hospitalier Régional d'Orléans · Tests: expression of a panel Reducing Systemic Inflammation in People on Antiretroviral Therapy NCT07030920Phase 21 site📍 Montreal Centre hospitalier de l'Université de Montréal (CHUM) · Tests: Fostemsavir Phase 1/2 Study of Chlamydia Trachomatis mRNA Vaccine in Adults Aged 18 to 29 Years NCT06891417Phase 1, Phase 27 sites📍 Bruce📍 Maroubra📍 Sydney Sanofi · Tests: Chlamydia mRNA Vaccine, Placebo Practice Facilitation as a Strategy to Improve Alcohol Treatment Adoption and Implementation in HIV Care NCT05241990NA3 sites📍 San Diego📍 Boston📍 Chapel Hill Johns Hopkins University · Tests: Practice Facilitation, Alcohol Stepped Care Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old) NCT05672927Phase 41 site📍 Galveston The University of Texas Medical Branch, Galveston · Tests: 9-valent HPV vaccine, 2 doses alternate timing, 9-valent HPV vaccine, 3 doses standard timing Reducing Mortality in Adults With Advanced HIV Disease (REVIVE) NCT05580666Phase 352 sites📍 Abidjan📍 Abidjan📍 Abidjan Population Health Research Institute · Tests: Azithromycin Oral Tablet, Placebo oral tablet HIV Testing Counselor-led Care to Catalyze Integration of PrEP Delivery in Family Planning Clinics NCT07089966NA1 site📍 Kisumu University of Washington · Tests: HTS counselor-led PrEP care model Treponemal Shedding, Load, and Viability, in Women and Men-who-have-sex-with-women-only With Early Infectious Syphilis: Implications for Transmission NCT07300254n/a9 sites📍 Melbourne📍 Shanghai📍 Shanghai Monash University · Tests: No Intervention: Observational Cohort Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine NCT07275333NA1 site📍 Zaporizhzhya Karolinska Institutet · Tests: HPV Self-Sampling Kit
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy